Differences

This shows you the differences between two versions of the page.

--- home:starting:physician:reluctant [04.15.2019] – [Ascertain if reluctance is a provider problem or a bureaucracy problem] sallieq
+++ home:starting:physician:reluctant [04.15.2019] – [Ascertain if reluctance is a provider problem or a bureaucracy problem] sallieq
@@ Line 163: / Line 163: @@
 ==== Ascertain if reluctance is a provider problem or a bureaucracy problem ====
-In Australia, physicians must now ring Canberra for permission to prescribe off-label.
+In Australia, physicians must now approach Canberra (federal bureaucracy) for permission to prescribe off-label.
-I expect some other countries also have centralised control, in which case patients may need to research  medical reasons other than MP, why they should take Olmesartan in preference to some more usual prescription
+<blockquote>//That is what I was told//, so I approached my local doctor in some trepidation armed with a bunch of references from the article on Science of Olmesartan and said "I think you will need these to support a prescription for off-label Olmetec".
+He simply smiled and wrote me 2 prescriptions: One for 40mg, One for 20 mg !</blockquote>
+I expect some other countries also have centralised control, in which case patients may need to research  medical reasons other than MP, why they should take Olmesartan in preference to some more usual prescription.
 === Specific research ===

home/starting/physician/reluctant.txt · Last modified: 09.14.2022 by 127.0.0.1